Abstract:Background Cisplatin has proved itself an effective therapeutic approach in a variety of solid tumors. However, its therapeutic concentration was limited since the presence of variant inevitable side effects. Nanoparticles (NPs) developed from amphiphilic copolymers have drawn great attention for prolonging drug residency in blood circulation, increasing tumor accumulation, reducing serum protein adherence and preventing uptake by the reticuloendothelial system (RES). Previously, we synthesized polyethylene glycol (PEG)- polycaprolactone (PCL) NPs as anticancer drug and had confirmed its efficacy in vitro. To comprehensively study the influences of cisplatin-loaded PEG-PCL copolymeric NPs, we enlarge the amount of murine models and applied more physical tests to offer a broader view of the impact that cisplatin-loaded PEG-PCL copolymeric NPs brought about. Methods We observed the physical alteration of hepatoma-bearing mice and the tumors after administration of cisplatin-loaded PEG-PCL nanoparticles (NPs). Cell uptake and apoptotic rates were measured through fluorescence microscopy and flowcytometry. Murine blood was collected and examined. Positron emission tomography/computed tomography (PET/CT) was utilized for the detection of tumor metabolic status. Results The biopsy and the measurement of tumor volume and murine weights have confirmed the therapeutic efficacy of cisplatin-loaded NPs and was positively related to the dosage of cisplatin. Fluorescence microscope images indicated a better cellular uptake rate of cisplatin-loaded NPs with intracellularly-aggregated, heterogeneous rhodamine B observed in LoVo cells. A decline of apoptotic rates in cisplatin-loaded NPs was measured. Blood tests exhibited less side effects in cisplatin-loaded NPs with higher level of white blood cells and lower aspartate transaminase (AST). PET/CT images revealed less intensity of FDG uptake in murine received higher dosage of cisplatin-loaded NPs. Conclusions Nanoparticles prepared from PEG-PCL/PCL hybrids could be a promising drug carrier for intratumoral delivery with greater efficacy and less side effects. This study provides a theoretical basis for possible clinical application. Legal entity responsible for the study Comprehensive Cancer Center of Drum-Tower Hospital Comprehensive Cancer Center of Drum-Tower Hospital Comprehensive Cancer Center of Drum-Tower Hospital. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest.

[Lethal Effects of Nanoliposome Encapsulated Cisplatin on Saos-2 Cells and Its Distribution in Nude Mice Bearing Human].

Nanoparticle Delivery of a Triple-Action Pt(iv) Prodrug to Overcome Cisplatin Resistance Via Synergistic Effect

Bio-inspired Cisplatin Nanocarriers for Osteosarcoma Treatment.

Anticancer effect of long-circulating nanometer liposome packaging cisplatin in vitro and in vivo

Pharmacokinetics of Cisplatin Packaged in a Nanometer Liposome

Development of Alendronate-conjugated Poly (Lactic-Co-glycolic Acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma

In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer.

Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer.

Cisplatin-Loaded Poly(L-Glutamic Acid)-G-Methoxy Poly(Ethylene Glycol) Nanoparticles As A Potential Chemotherapeutic Agent Against Osteosarcoma

Study on Targeting Distribution of Cisplatin Stealth Nanoparticles in Normal Mice

Synergistic Effect of Docetaxel Combined with Cisplatin on Inhibiting Human Osteosarcoma in Nude Mice

Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.

Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy

The Effects of Oxaliplatin on the Invasion and Metastatic Potential of Orthotopic Hepatocellular Carcinoma Nude Mice Model Established with Fluorescent HepG2 Cells

Biodistribution of Cisplatinloaded Magnetic Iron Oxide Nanoparticles in Nude Mice Bearing Human Head and Neck Cancer

Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects

Effects of Cisplatin-Alginate Conjugate Liposomes in Cervical Cancer-Bearing Nude Mice

Enhanced Treatment Effect of Nanoparticles Containing Cisplatin and a GSH-reactive Probe Compound.

Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines

Superior Antitumor Efficiency of Cisplatin-Loaded Nanoparticles by Intratumoral Delivery with Decreased Tumor Metabolism Rate

In Vivo Evaluation of Cisplatin-Loaded PEG-PCL Block Copolymeric Nanoparticles for Anticancer Drug Delivery